Intrinsic Value of S&P & Nasdaq Contact Us

GRAIL, Inc. GRAL NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
56/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$88.00
+74.3%

GRAIL, Inc. (GRAL) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.

The consensus price target is $88.00 (low: $60.00, high: $130.00), representing an upside of 74.3% from the current price $50.49.

Analysts estimate Earnings Per Share (EPS) of $-51.26 and revenue of $0.12B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-63.54 vs est $-51.26 (missed -23.9%). 2025: actual $-11.11 vs est $-11.41 (beat +2.6%). Analyst accuracy: 89%.

GRAL Stock — 12-Month Price Forecast

$88.00
▲ +74.29% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for GRAIL, Inc., the average price target is $88.00, with a high forecast of $130.00, and a low forecast of $60.00.
The average price target represents a +74.29% change from the last price of $50.49.
Highest Price Target
$130.00
Average Price Target
$88.00
Lowest Price Target
$60.00

GRAL Analyst Ratings

Buy
4
Ratings
3 Buy
1 Hold
Based on 4 analysts giving stock ratings to GRAIL, Inc. in the past 3 months
Rating breakdown
Buy
3 75%
Hold
1 25%
75%
Buy
3 analysts
25%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — GRAL

89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$63.54 vs Est –$51.26 ▼ 19.3% off
2025 Actual –$11.11 vs Est –$11.41 ▲ 2.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — GRAL

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.126B vs Est $0.122B ▲ 2.7% off
2025 Actual $0.147B vs Est $0.147B ▲ 0.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message